Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750616 · ClinicalTrials.gov registry record · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
A Phase 2 study of Acute Kidney Injury and Ischemia Reperfusion Injury, sponsored by Kaiser Permanente.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 304
- Enrollment target
- 1
- Study location
NCT04750616 is a Phase 2 study of Acute Kidney Injury and Ischemia Reperfusion Injury that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 304 participants, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04750616, a Phase 2 study of Acute Kidney Injury and Ischemia Reperfusion Injury, is actively recruiting participants, sponsored by Kaiser Permanente.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Niacinamide
Study Locations (1)
California
- Kaiser Permanente San Francisco Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04750616
The ClinicalTrials.gov registry entry for NCT04750616 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (87% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04750616 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04750616 about?
NCT04750616 is a clinical study titled "NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial". A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery
What is the current status of trial NCT04750616?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 304 participants. The study started on 2021-09-13. Estimated completion is 2025-06-30.
What conditions does trial NCT04750616 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Ischemia Reperfusion Injury, Myocardial Injury.
What interventions are being tested in trial NCT04750616?
The interventions under investigation include: Placebo (DRUG), Niacinamide (DRUG).
Who is sponsoring clinical trial NCT04750616?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04750616 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
RECRUITING · Phase 2
-
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
RECRUITING · Phase 2
-
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)
RECRUITING · Phase 2
-
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
RECRUITING · Phase 2
-
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.